Elasomeran

3 trials JAnti-infectives

Filter these 3 trials by condition, phase, country and more.

Open in Search →

3 Registered trials

0 Recruiting

2 Completed trials

4 Sponsors

3 Countries

Phase IV

Phase IV: 3

Indications tested

Sponsors using this IMP

Finnish Institute For Health And Welfare 1 Gentofte Hospital 1 Moderna Inc. 1 National Institute For Infectious Diseases Lazzaro Spallanzani 1

All trials

3 total

Temporal kinetics of antibody and cellular response markers and relative impact of revaccination in patients recovered from COVID-19 after t… Pending

2024-514071-17-00 Phase IV 1 country National Institute For Infectious Diseases Lazzaro Spallanzani
A Phase 4 Pragmatic, Randomized Trial to Evaluate the Effectiveness and Safety of mRNA-1273 Variant-Containing Vaccine Formulation Against S… Ended

2025-523841-82-00 Phase IV 1 country Gentofte Hospital; Moderna Inc.
COVID-19 vaccine immunology Ended

2024-517357-27-00 Phase IV 1 country Finnish Institute For Health And Welfare

Showing 1–3 of 3 trials

← All drugs A–Z